Job Description
Image Analysis Technologist- Irving, Texas - Monday - Friday 8am-430 pm
We are looking for the following:
Basic Purpose:
The Breast Prognostics Technician will, under the direction of the Supervisor of Breast Prognostics/Cytology and the Director of Breast Prognostics and/ or Cytology Technical Supervisor, be responsible for performing all technical duties associated with the Breast Prognostics, FISH and non-gyn Cytology.
Reviews and approves, with direction of the Supervisor, Director, or Technical Supervisor positive, and or negative controls run with each FISH (HER2, and Urovysion) batch.
Understands the criteria for the selection of controls.
Provide feedback to the immunohistochemistry department on the quality of IHC stains as well as the use for future potential positive controls.
Maintains log for the performance of each antibody in a control surveillance log. Reports to the Supervisor Director, Technical Supervisor any variances or potential concerns.
Maintains log for controls run for FISH assay. Reports to the Supervisor, Director, or Technical Supervisor any variances or potential concerns.
Maintains temperature logs, maintenance logs, cytology workloads, and other pertinent logs. These are provided monthly to the supervisor.
Quantitates all patient specimens for breast prognostics, bladder cancer FISH, or HER2 FISH under the direction of appropriate personnel, Supervisor, Director, or Technical Supervisor. Notify Supervisor for any concerns.
Quantitation of IHC stains is performed, and included in the prognostic report.
Provides all slides and paper work for the signing pathologist to review and edit. Images for FISH testing are available in Image file folder for the pathologist to review.
Edits, and reviews demographics for all necessary items needed in the final report. Puts reviewed report into the pathologist's queue for potential release of prognostic report.
A running log is maintained for concordance variances between IHC and FISH in gastric and breast cancer. Notify Supervisor of any discrepancies.
A running log is maintained for ER/PR reported results. Reported results are compared to published guidelines. Each individual pathologist is analyzed as well. Notify Supervisor of any discrepancies.
Learns and performs technical staining portion of HER2/Bladder Cancer FISH testing.
Performs and quantitates HER2/Bladder FISH under the direction of the Director of Breast Prognostics, Cytology Technical Supervisor, and/or appropriate personnel. Notify Supervisor of any concerns.
Learns and understands Pathway reporting.
Follows COGNOS reports which monitor turnaround time for Breast Prognostics reports and bladder cancer FISH.
Understands and complies with all safety regulations involved in each testing phase.
Understand tissue morphology which involves direct supervision from qualified personnel or pathologist to perform quantitative analysis for prognostictesting.
A microscopic evaluation is performed for individual IHC test quantitated in the Breast Prognostics.
A microscopic evaluation is performed for HER2 FISH prognostic testing.
Urovysion testing for Bladder cancer is performed using the lkonisys' equipment, or a manual microscopic evaluation is performed, if needed.
Participates in CAP proficiency testing, and understands PT proficiency guidelines for handling of proficiency material.
Other duties as assigned by Supervisor, Director of Breast Prognostics, or Cytology Technical Supervisor.
Duties and Responsibilities: Cytotechnologist
Under general supervision, examine microscopically non-gynecologic slides for infectious, reactive/reparative and abnormal cells.Refer appropriate cases for hierarchical review.
Identify problems that may adversely affect test performance or reporting of results. Refer to supervisor/manager and document corrective action taken.
Fulfill the responsibilities as listed in CLIA(CFR 493.1485):
Document interpretation results of each specimen examined or reviewed.
For each 24-hour period, document the total number of slides examined or reviewed in the laboratory as well as the total number of slides examined or reviewed in any other laboratory or for any other employer.
Document the number of hours spent examining slides in each 24-hour period.
Maintain and provide evidence of all required qualifications including ASCP, state licenses and liquid based cytology certification, as applicable.
Maintain familiarity with CLIA regulations, as applicable to cytology.
Notify supervisor, and Cytology Technical Supervisor of outside employment. Approval must be given.
Other Duties:
Maintain specimen integrity and patient identification of all samples examined.
JOB RESPONSIBILITIES:
* Processing biopsies, cutting and imaging using the Transmission Electron Microscope.
* Developing SOPs for Renal Laboratory.
* Responsible for the day-to-day operations of the Renal Service.
* Cross training of EM process.
* Special Projects such as organizing Renal Conferences.
* Adheres to all established laboratory safety requirements.
* Maintains current SOPs and incorporates BPTs into department.
* Maintains patient confidentiality and HIPAA compliance.
* Performs other job related duties as assigned by competent authority.
JOB REQUIREMENTS:
* Bachelors degree in Science
* Knowledge, Skills and Abilities
* Broad knowledge of technical aspects of all tests performed and equipment utilized in the department.
* Good written and verbal communication skills required.
* Required to handle biological samples and potentially hazardous chemicals.
Secaucus, NJ
Company Overview
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 46,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
At a Glance
Quest Diagnostics is the world’s leading provider of diagnostic information services
Generated 2018 revenues of approximately $7.53 billion
Publicly trades common stock on the New York Stock Exchange (NYSE: DGX). More in Investor Relations
Ranks as a component of the S&P 500
Touches the lives of 30 percent of American adults each year
Serves about half of the physicians and hospitals in the U.S
Access to approximately 90% of U.S. insured lives
Engages workforce of about 46,000 employees dedicated to putting patients first every day
More than 6,600 patient access points, the most extensive network in the U.S.,
including phlebotomists in physician offices and more than 2,250 of our own
patient service centers
A medical and scientific staff of more than 600 M.D.s and Ph.D.s
Logistics capabilities, that include approximately 3,750 courier vehicles and 25 aircraft that collectively make tens of thousands of stops daily
Offers physicians a test menu that is industry leading in breadth and innovation. Our test menu ranges from routine biological tests to complex and specialized molecular and gene-based testing as well as anatomic pathology
Provides a broad range of solutions for employers, including workplace drug testing for employers and government agencies; the Blueprint for Wellness employee wellness service; and risk assessment services for the life insurance industry
Publishes original research in peer reviewed publications, at medical and scientific conferences, and as a public service. Quest Diagnostics Health Trends reports examine trends in diseases based on the company’s United States database. Quest Diagnostics Drug Testing Index (DTI) reports examine trends in workplace drug testing, and have been considered a benchmark for U.S. workforce drug positivity trends since 1988
Recognition
Named to Fortune Magazine's 2019 World's Most Admired Companies list in the Health Care industry category of "Pharmacy and Other Services" for the third consecutive year
Among FORTUNE® Magazine's 2018 Fortune 500® companies
Ranked on the Forbes® 2018 Global 2000
Ranked on the “Barron’s 500” list of top-performing large companies for 2017
Named a member of the Dow Jones® Sustainability World and North America indexes since 2004 (DJSI World) and 2005 (DJSI North America). The Dow Jones Sustainability World Index represents the top 10% of the leading sustainability companies out of the biggest 2,500 companies in the Dow Jones Global Total Stock Market Index
Earned a place on the annual Newsweek Green Rankings, for the fourth consecutive year on the 2017 U.S. list
Consistently named one of the best places to work in U.S. business journal rankings, including Forbes® 2018 America's Best Large Employers
Achieved Cancer Gold Standard™ accreditation from the CEO Roundtable on Cancer, recognizing our important actions to reduce the cancer risk of employees and their families
Received a rating of 100 from the Human Rights Campaign on the 2018 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBT Equality"
Named a DiversityInc Noteworthy Company for the second consecutive year in 2018
Read more about awards and honors.
Read more about our Reputation Honors and Corporate Social Responsibility programs.
Products and Services
Diagnostics information services
Clinical trials
Healthcare IT
Wellness & risk management
Drug Screening
Read more about products and services.
Operations
Headquarters in the U.S.: 500 Plaza Drive, Secaucus, New Jersey 07094
Approximately 2,200 patient locations and dozens of clinical laboratories throughout the U.S.
In addition to the U.S., Quest Diagnostics operates clinical laboratories in laboratory facilities in Gurgaon, India; Heston, England; Mexico City, Mexico; and San Juan, Puerto Rico